Show simple item record

dc.contributor.advisorKhetani, Salman R.
dc.contributor.authorLin, Christine
dc.date.accessioned2018-06-12T16:13:44Z
dc.date.available2020-06-07T16:13:44Z
dc.date.submitted2018
dc.identifierLin_colostate_0053A_14637.pdf
dc.identifier.urihttps://hdl.handle.net/10217/189267
dc.description2018 Spring
dc.descriptionIncludes bibliographical references.
dc.description.abstractIn vitro liver models have many applications in disease modeling and drug screening. Micropatterned cocultures (MPCCs) of primary human hepatocytes (PHHs) and supportive stromal cells have been shown to display high hepatic functions for long-term drug and disease studies. However, MPCCs lack liver non-parenchymal cells (NPCs) and the proper microenvironmental cues that can play important roles in conditions such as drug-induced liver injury (DILI), which is the leading cause of the prelaunch attrition and post-market withdrawal of pharmaceuticals, or diseases such as viral hepatitis. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infection are major health problems that affect >250 million and ~130-170 million people worldwide, respectively, and the development of therapeutics has been hindered due to the lack of models in which to study human response to virus and drugs. Thus, long-term in vitro models that can be used to study the progression of viral infection and drug pharmacodynamics are required to develop safe and efficacious therapeutics. These models must also be human-relevant due to the narrow host tropism of hepatitis B and C and differences in liver pathways across species. Thus, the goal of this dissertation is to augment the MPCC model to include the relevant substrates and cell types for the study of cell-cell interactions in diseases such as hepatitis and DILI. Biomaterials can present important microenvironmental factors that interact with cells. Chitosan and heparin polyelectrolyte multilayers (PEMs) were utilized as a substrate to present extracellular matrix (ECM) proteins and growth factors (GF) to hepatocyte cultures. Liver biomatrix (LBM) derived from human and porcine sources were also assessed as substrates since LBM contains both soluble and insoluble cues that are usually found in the liver in vivo. In addition to improving the MPCC substrate, liver NPCs, such as primary human Kupffer cells (KCs), were incorporated into the MPCC model since KCs play key roles in immune responses and inflammation. This work will be used to establish models that integrate multiple liver cell types on a physiologically-relevant substrate to study disease states such as hepatitis and DILI towards creating effective therapeutics.
dc.languageEnglish
dc.language.isoeng
dc.publisherColorado State University. Libraries
dc.rightsCopyright of the original work is retained by the author.
dc.titleEngineering complex liver models for drug screening and infectious diseases : a biomaterials and co-culture perspective
dc.typeThesis
dc.rights.accessEmbargo Expires: 06/07/2020
dcterms.embargo.terms2020-06-07
dcterms.embargo.expires2020-06-07
dc.contributor.committeememberGustafson, Daniel
dc.contributor.committeememberKipper, Matthew
dc.contributor.committeememberPagliassotti, Michael
thesis.degree.nameDoctor of Philosophy (Ph.D.)
thesis.degree.levelDoctoral
thesis.degree.disciplineBioengineering
thesis.degree.grantorColorado State University


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record